BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 15063568)

  • 1. Immunogenic properties of the Salmonella atypical fimbriae in BALB/c mice.
    Strindelius L; Folkesson A; Normark S; Sjöholm I
    Vaccine; 2004 Mar; 22(11-12):1448-56. PubMed ID: 15063568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H/HeJ mice.
    Strindelius L; Filler M; Sjöholm I
    Vaccine; 2004 Sep; 22(27-28):3797-808. PubMed ID: 15315861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal sublingual vaccination with Salmonella proteins and adjuvant cholera toxin or CpG oligodeoxynucleotides induces mucosal and systemic immunity in mice.
    Huang CF; Wang CC; Wu TC; Wu KG; Lee CC; Peng HJ
    J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):262-71. PubMed ID: 18376242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of immune responses and prevention of alveolar bone loss by intranasal administration of mice with Porphyromonas gingivalis fimbriae and recombinant cholera toxin B subunit.
    Takahashi Y; Kumada H; Hamada N; Haishima Y; Ozono S; Isaka M; Yasuda Y; Tochikubo K; Umemoto T
    Oral Microbiol Immunol; 2007 Dec; 22(6):374-80. PubMed ID: 17949339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on the induction of the humoral immune responses to Bacteroides gingivalis fimbrial antigen in mice].
    Shimauchi H
    Osaka Daigaku Shigaku Zasshi; 1990 Jun; 35(1):60-77. PubMed ID: 1983739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Starch microparticles as a vaccine adjuvant: only uptake in Peyer's patches decides the profile of the immune response.
    Stertman L; Lundgren E; Sjöholm I
    Vaccine; 2006 Apr; 24(17):3661-8. PubMed ID: 16513226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral vaccination against diphtheria using polyacryl starch microparticles as adjuvant.
    Rydell N; Sjöholm I
    Vaccine; 2004 Mar; 22(9-10):1265-74. PubMed ID: 15003656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral immunization of piglets with recombinant F4 fimbrial adhesin FaeG monomers induces a mucosal and systemic F4-specific immune response.
    Verdonck F; Cox E; Van der Stede Y; Goddeeris BM
    Vaccine; 2004 Oct; 22(31-32):4291-9. PubMed ID: 15474721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sublingual vaccination with sonicated Salmonella proteins and mucosal adjuvant induces mucosal and systemic immunity and protects mice from lethal enteritis.
    Huang CF; Wu TC; Wu CC; Lee CC; Lo WT; Hwang KS; Hsu ML; Peng HJ
    APMIS; 2011 Jul; 119(7):468-78. PubMed ID: 21635554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular adjuvant mC3d enhances the immunogenicity of FimA from type I fimbriae of Salmonella enterica serovar Enteritidis.
    Musa HH; Zhang WJ; Lv J; Duan XL; Yang Y; Zhu CH; Li HF; Chen KW; Meng X; Zhu GQ
    J Microbiol Immunol Infect; 2014 Feb; 47(1):57-62. PubMed ID: 23352331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral vaccination against Helicobacter pylori with recombinant cholera toxin B-subunit.
    Kubota E; Joh T; Tanida S; Sasaki M; Kataoka H; Watanabe K; Itoh K; Oshima T; Ogasawara N; Togawa S; Wada T; Yamada T; Mori Y; Fujita F; Shimura T; Ohara H; Isaka M; Yasuda Y; Itoh M
    Helicobacter; 2005 Aug; 10(4):345-52. PubMed ID: 16104951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal immunization with recombinant MOMP genetically linked with modified cholera toxin confers protection against Chlamydia trachomatis infection.
    Singh SR; Hulett K; Pillai SR; Dennis VA; Oh MK; Scissum-Gunn K
    Vaccine; 2006 Feb; 24(8):1213-24. PubMed ID: 16194585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529.
    Mason KW; Zhu D; Scheuer CA; McMichael JC; Zlotnick GW; Green BA
    Vaccine; 2004 Sep; 22(25-26):3449-56. PubMed ID: 15308371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Starch microparticles as an adjuvant in immunisation: effect of route of administration on the immune response in mice.
    Stertman L; Strindelius L; Sjöholm I
    Vaccine; 2004 Jul; 22(21-22):2863-72. PubMed ID: 15246622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization.
    Hotomi M; Ikeda Y; Suzumoto M; Yamauchi K; Green BA; Zlotnick G; Billal DS; Shimada J; Fujihara K; Yamanaka N
    Vaccine; 2005 Jan; 23(10):1294-300. PubMed ID: 15652672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.
    Cong H; Gu QM; Jiang Y; He SY; Zhou HY; Yang TT; Li Y; Zhao QL
    Parasite Immunol; 2005; 27(1-2):29-35. PubMed ID: 15813720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice.
    Isaka M; Zhao Y; Nobusawa E; Nakajima S; Nakajima K; Yasuda Y; Matsui H; Hasegawa T; Maeyama J; Morokuma K; Ohkuma K; Tochikubo K
    Microbiol Immunol; 2008 Feb; 52(2):55-63. PubMed ID: 18380802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasopharyngeal-associated lymphoreticular tissue (NALT) immunity: fimbriae-specific Th1 and Th2 cell-regulated IgA responses for the inhibition of bacterial attachment to epithelial cells and subsequent inflammatory cytokine production.
    Yanagita M; Hiroi T; Kitagaki N; Hamada S; Ito HO; Shimauchi H; Murakami S; Okada H; Kiyono H
    J Immunol; 1999 Mar; 162(6):3559-65. PubMed ID: 10092814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular antigens from Salmonella enteritidis induce effective immune response in mice after oral vaccination.
    Strindelius L; Degling Wikingsson L; Sjöholm I
    Infect Immun; 2002 Mar; 70(3):1434-42. PubMed ID: 11854230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.